Patents by Inventor James Ryland

James Ryland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12547871
    Abstract: Embodiments regard neural network (NN) obfuscation. A method can include receiving data representing the NN architecture. The NN architecture includes neurons, each neuron comprising corresponding neuron input weights, an activation function, and one or more interconnections between one or more other neurons of the neurons. The method can include mapping inputs to the neurons from a continuous domain to a discrete domain resulting in discretized neuron inputs. The method can include applying the activation function to the discretized neuron inputs resulting in discretized neuron outputs.
    Type: Grant
    Filed: August 16, 2022
    Date of Patent: February 10, 2026
    Assignee: Raytheon Company
    Inventors: James Ryland, Philip A. Sallee
  • Publication number: 20250238458
    Abstract: Systems, devices, methods, and computer-readable media for completing an ontology. A method can include providing, to a machine learning (ML) model, unstructured data including a vocabulary of words of an ontology, receiving, from the ML model, a first learned term relationship model indicating respective relationships, the respective relationships indicating which words of the vocabulary of words are related to each other, identifying a relationship of the respective relationships that is (i) present in the first ontology and (ii) absent from a second ontology, providing a prompt including data indicating the relationship to a large language model (LLM), receiving a result from the LLM indicating a type of the relationship, and adding the relationship and the type to the second ontology.
    Type: Application
    Filed: January 17, 2025
    Publication date: July 24, 2025
    Inventor: James Ryland
  • Publication number: 20240256866
    Abstract: Embodiments regard improving machine learning (ML) training dataset generation. A method includes receiving or generating, by a scene editor, an image, augmenting, using procedural generation, the image to include a three-dimensional (3D) model of an object resulting in a synthetic image, and generating, by a generative model and based on the synthetic image, a realistic image.
    Type: Application
    Filed: August 9, 2023
    Publication date: August 1, 2024
    Inventors: James Ryland, Philip A. Sallee, Steven D. Werner
  • Publication number: 20240062036
    Abstract: Embodiments regard neural network (NN) obfuscation. A method can include receiving data representing the NN architecture. The NN architecture includes neurons, each neuron comprising corresponding neuron input weights, an activation function, and one or more interconnections between one or more other neurons of the neurons. The method can include mapping inputs to the neurons from a continuous domain to a discrete domain resulting in discretized neuron inputs. The method can include applying the activation function to the discretized neuron inputs resulting in discretized neuron outputs.
    Type: Application
    Filed: August 16, 2022
    Publication date: February 22, 2024
    Inventors: James Ryland, Philip A. Sallee
  • Publication number: 20160237149
    Abstract: Provided herein is a method for producing an antibody, such as an anti-TNF? antibody (e.g., infliximab) having a C-terminal lysine content of about 20% to about 70%, and a sialic acid content of about 1% to about 20%, comprising culturing a zinc-responsive host cell transfected with DNA encoding the antibody in a culture medium comprising at least 0.5 ?M zinc; and controlling the concentration of zinc in the culture medium, thereby producing the antibody.
    Type: Application
    Filed: December 23, 2015
    Publication date: August 18, 2016
    Inventors: Marcel Flikweert, Charles Goochee, Francis Maslanka, Franciscus Johannes Ignatius Nagel, James Ryland, Eugene Schaefer
  • Publication number: 20140273092
    Abstract: Provided herein is a method for producing an antibody, such as an anti-TNF? antibody (e.g., infliximab) having a C-terminal lysine content of about 20% to about 70%, and a sialic acid content of about 1% to about 20%, comprising culturing a zinc-responsive host cell transfected with DNA encoding the antibody in a culture medium comprising at least 0.5 ?M zinc; and controlling the concentration of zinc in the culture medium, thereby producing the antibody.
    Type: Application
    Filed: March 13, 2014
    Publication date: September 18, 2014
    Applicants: Janssen Biologics B.V., Janssen Biotech, Inc.
    Inventors: Marcel Flikweert, Charles Goochee, Francis Maslanka, Franciscus Johannes Ignatius Nagel, James Ryland, Eugene Schaefer